Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
Hachet-Haas, Muriel, Balabanian, Karl, Rohmer, François, Pons, Françoise, Franchet, Christel, Lecat, Sandra, Chow, Ken Y.C., Dagher, Rania, Gizzi, Patrick, Didier, Bruno, Lagane, Bernard, Kellenberger, Esther, Bonnet, Dominique, Baleux, Françoise, Haiech, Jacques, Parmentier, Marc, Frossard, Nelly, Arenzana-Seisdedos, Fernando, Hibert, Marcel, Galzi, Jean-luc
Published in The Journal of biological chemistry (22.08.2008)
Published in The Journal of biological chemistry (22.08.2008)
Get full text
Journal Article
817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties
Blayo, Anne-Laure, Deshons, Laurène, Dumont, Alexia, Franchet, Christel, Halter, Célia, Herbin, Ludovic, Hommet, Gaël, Mayer, Stanislas, Bessede, Alban, Nafia, Imane, Sidhoum, Marjorie, Leroy, Xavier, Schann, Stéphan
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Abstract LB123: A high value pharmacological platform dedicated to the real time study of stimulatory immune checkpoint signaling pathways
MAURIN, Alice GENTIL DIT, FRANCHET, Christel, SCHANN, Stephan, LEROY, Xavier
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 6308: Development of a pharmacological platform to study in real time immune checkpoints signaling pathways: validation with therapeutic mAbs and small molecules
Maurin, Alice Gentil Dit, Franchet, Christel, Leroy, Xavier, Schann, Stephane
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 6697: DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties
Blayo, Anne-Laure, Deshons, Laurène, Dumont, Alexia, Franchet, Christel, Halter, Célia, Herbin, Ludovic, Hommet, Gaël, Mayer, Stanislas, Bessede, Alban, Nafia, Imane, Sidhoum, Marjorie, Leroy, Xavier, Schann, Stephan
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies
Fer, Mickael, Amalric, Camille, Arban, Roberto, Baron, Luc, Ben Hamida, Sami, Breh-Schlanser, Petra, Cui, Yunhai, Darcq, Emmanuel, Eickmeier, Christian, Faye, Vincent, Franchet, Christel, Frauli, Mélanie, Halter, Célia, Heyer, Marjorie, Hoenke, Christoph, Hoerer, Stefan, Hucke, Oliver T., Joseph, Christophe, Kieffer, Brigitte L., Lebrun, Louison, Lotz, Noémie, Mayer, Stanislas, Omrani, Azar, Recolet, Mandy, Schaeffer, Laurent, Schann, Stephan, Schlecker, Annette, Steinberg, Edith, Viloria, Mélanie, Würstle, Klaus, Young, Kyle, Zinser, Alexander, Montel, Florian, Klepp, Julian
Published in Journal of medicinal chemistry (11.07.2024)
Published in Journal of medicinal chemistry (11.07.2024)
Get full text
Journal Article
Chemical Switch of a Metabotropic Glutamate Receptor 2 Silent Allosteric Modulator into Dual Metabotropic Glutamate Receptor 2/3 Negative/Positive Allosteric Modulators
Schann, Stephan, Mayer, Stanislas, Franchet, Christel, Frauli, Mélanie, Steinberg, Edith, Thomas, Mireille, Baron, Luc, Neuville, Pascal
Published in Journal of medicinal chemistry (23.12.2010)
Published in Journal of medicinal chemistry (23.12.2010)
Get full text
Journal Article
Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist
Iturrioz, Xavier, Alvear-Perez, Rodrigo, De Mota, Nadia, Franchet, Christel, Guillier, Fabrice, Leroux, Vincent, Dabire, Hubert, Le Jouan, Melissande, Chabane, Hadjila, Gerbier, Romain, Bonnet, Dominique, Berdeaux, Alain, Maigret, Bernard, Galzi, Jean-Luc, Hibert, Marcel, Llorens-Cortes, Catherine
Published in The FASEB journal (01.05.2010)
Published in The FASEB journal (01.05.2010)
Get more information
Journal Article
Abstract 2946: Depleting hCCR8 mAb Therapy #1: Characterization of a broad collection of anti-hCCR8 mAbs
Vermot-Desroches, Claudine, Richert, Iseulys, Schappler, Malaury, Maurin, Alice Gentil Dit, Jeannelle, Megane, Rose, Solene, Baron, Luc, Ruet, Quentin, Dietsch, Camille, Urquia, Pauline, Ayachi, Safia, Blanchard, Orphee, Fernandez, Maria Dolores Garcia, Franchet, Christel, Lenne, Nathalie, Schann, Stephan
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 684: DT-9045, a novel PAR2 inhibitor with best-in-class properties that reduces resistance to both EGFR-targeting therapies and immunotherapy in oncology models
Brugat, Thibaut, Kadiri, Maleck, Aouad, Samya, Blayo, Anne-Laure, Rugeri, Baptiste, Mousson, Antoine, Janvier, Aurélie, Steinberg, Edith, Baron, Luc, Recolet, Mandy, Wirth, Xavier, Garcia-Leon, Maria Jesus, Ruet, Quentin, Semache, Meriem, Sabbagh, Laurent, Blanchard, Orphée, Franchet, Christel, Mayer, Stanislas, Stagg, John, Lenne, Nathalie, Schann, Stephan
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 2945: Depleting hCCR8 mAb Therapy #2: Selection of candidates for the development of innovative depleting anti CCR8 therapeutic antibodies to control the immunosuppressive tumor microenvironment
Maurin, Alice Gentil Dit, Richert, Iseulys, Fernandez, Maria Dolores Garcia, Janvier, Aurélie, Rose, Solene, Jeannelle, Megane, Chraa, Dounia, Dietsch, Camille, Urquia, Pauline, Ruet, Quentin, Schappler, Malaury, Baron, Luc, Ayachi, Safia, Blanchard, Orphée, Franchet, Christel, Fontayne, Alexandre, Vermot-Desroches, Claudine, Schann, Stephan, Lenne, Nathalie
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 4961: Novel biased PAR2 inhibitors with best-in-class properties reduce resistance to both chemotherapy and immunotherapy in oncology models
Brugat, Thibaut, Bergami, Francesco, Rugeri, Baptiste, Janvier, Aurélie, Steinberg, Edith, Baron, Luc, Recolet, Mandy, Wirth, Xavier, Semache, Meriem, Mousson, Antoine, Dietsch, Camille, Ruet, Quentin, Blanchard, Orphée, Jacoberger-Foissac, Célia, Cousineau, Isabelle, Kadiri, Maleck, Blayo, Anne-Laure, Franchet, Christel, Mayer, Stanislas, Stagg, John, Lenne, Nathalie, Schann, Stephan
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Collection of traceable compounds and uses thereof
PATTUS, FRANC, HIBERT, MARCEL, GALZI, JEAN-LUC, GUILLIER, FABRICE, FRANCHET, CHRISTEL
Year of Publication 22.09.2011
Get full text
Year of Publication 22.09.2011
Patent
Collections of traceable compounds and uses thereof
PATTUS, FRANC, HIBERT, MARCEL, GALZI, JEAN-LUC, GUILLIER, FABRICE, FRANCHET, CHRISTEL
Year of Publication 01.09.2011
Get full text
Year of Publication 01.09.2011
Patent